Capital Fund Management (CFM)
BPMC

Capital Fund Management (CFM)’s Blueprint Medicines BPMC Stock Holding History

Capital Fund Management (CFM)’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,820
Closed -$1.52M – 2449
2025
Q2 		$1.52M Sell
11,820
-79,672
-87% -$8.28M ﹤0.01% 1818
2025
Q1 		$8.1M Buy
91,492
+1,587
+2% +$155K 0.02% 777
2024
Q4 		$7.84M Buy
89,905
+18,483
+26% +$1.69M 0.02% 865
2024
Q3 		$6.61M Buy
71,422
+18,186
+34% +$1.81M 0.02% 894
2024
Q2 		$5.74M Buy
+53,236
New +$5.33M 0.02% 888
2023
Q3 		– Sell
-26,860
Closed -$1.7M – 1936
2023
Q2 		$1.7M Sell
26,860
-98,775
-79% -$5.37M 0.01% 1242
2023
Q1 		$5.65M Sell
125,635
-52,659
-30% -$2.37M 0.03% 696
2022
Q4 		$7.81M Buy
178,294
+75,534
+74% +$3.62M 0.05% 481
2022
Q3 		$6.77M Buy
102,760
+41,954
+69% +$2.69M 0.05% 443
2022
Q2 		$3.07M Buy
60,806
+17,419
+40% +$1.02M 0.03% 666
2022
Q1 		$2.77M Buy
+43,387
New +$3.11M 0.02% 824
2020
Q1 		– Sell
-5,877
Closed -$471K – 1572
2019
Q4 		$471K Buy
+5,877
New +$440K ﹤0.01% 1415
2018
Q3 		– Sell
-42,400
Closed -$2.69M – 1969
2018
Q2 		$2.69M Buy
+42,400
New +$3.37M 0.01% 967

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Capital Fund Management (CFM)'s BPMC Position: Q3 2025 in Review

Capital Fund Management (CFM) sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 11,820 shares — an estimated $1.52M sold.

Capital Fund Management (CFM) first reported a position in BPMC in Q2 2018 and held it in 13 quarters. The position peaked at $8.1M in Q1 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Capital Fund Management (CFM) reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 11,820 Blueprint Medicines shares in Q3 2025, an estimated $1.52M.
  • Capital Fund Management (CFM) first reported a position in Blueprint Medicines in Q2 2018 and held it in 13 quarters.
  • Capital Fund Management (CFM)'s Blueprint Medicines position peaked at $8.1M in Q1 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2025, filed 13 Nov 2025.